These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8818056)

  • 21. A sensitive spectrophotometric method for the determination of H2-receptor antagonists by means of N-bromosuccinimide and p-aminophenol.
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Acta Pharm; 2008 Mar; 58(1):87-97. PubMed ID: 18337210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of nizatidine in extemporaneous oral liquid preparations.
    Lantz MD; Wozniak TJ
    Am J Hosp Pharm; 1990 Dec; 47(12):2716-9. PubMed ID: 1980576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
    Nakamura H; Sano H; Yamazaki M; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
    Ahmed S; Elshaboury SR; Mohamed NA; Farrag S
    J Chromatogr Sci; 2017 Sep; 55(8):818-831. PubMed ID: 28486578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Celle G
    Am J Gastroenterol; 1991 Mar; 86(3):281-4. PubMed ID: 1671805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: a comparison with structurally related compounds.
    Meredith CG; Speeg KV; Schenker S
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):315-24. PubMed ID: 2858133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
    Ashiru DA; Patel R; Basit AW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):235-40. PubMed ID: 18006395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the solution degradation products of etintidine, an H2-receptor antagonist.
    Oyler AR; Naldi RE; Stefanick SM; Lloyd JR; Graden DA; Cotter ML
    J Pharm Sci; 1989 Jan; 78(1):21-4. PubMed ID: 2565383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of nizatidine on hepatic drug metabolism in man.
    Secor JW; Speeg KV; Meredith CG; Johnson RF; Snowdy P; Schenker S
    Br J Clin Pharmacol; 1985 Dec; 20(6):710-3. PubMed ID: 2868746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic-interchange program for oral histamine H2-receptor antagonists.
    Chase SL; Peterson AM; Wordell CJ
    Am J Health Syst Pharm; 1998 Jul; 55(13):1382-6. PubMed ID: 9659966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of nizatidine in total nutrient admixtures.
    Hatton J; Holstad SG; Rosenbloom AD; Westrich T; Hirsch J
    Am J Hosp Pharm; 1991 Jul; 48(7):1507-10. PubMed ID: 1679293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPLC fluorescence method for the determination of nizatidine in human plasma and its application to pharmacokinetic study.
    Çakar MB; Ulu ST
    Luminescence; 2014 Jun; 29(4):357-61. PubMed ID: 23836529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The voltammetric behavior of nizatidine and its determination in biological fluids.
    Al-Majed AA; Belal F; Al-Obaid AM; Dawoud AH
    J Pharm Biomed Anal; 1999 Nov; 21(2):319-26. PubMed ID: 10703986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.